{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:59:57Z","timestamp":1785387597098,"version":"3.55.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This article reviews the clinical status and treatment challenges of cancer-related depressive states, clarifies the mechanism of action of esketamine\u2014a novel rapid-acting antidepressant\u2014compares its efficacy with traditional drugs, evaluates safety and tolerability, and summarizes clinical evidence to support clinical practice and research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>By searching databases such as PubMed, Web of Science, and Cochrane Library, We conducted a structured review of the available literature on the mechanism of esketamine in the treatment of cancer-related depressive states in recent years, including mechanism studies, clinical trials, and review articles. We focused on its regulation of NMDA receptors, the impact on BDNF expression, synaptic plasticity, and neural circuit remodeling, and compared its efficacy and safety with traditional antidepressants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Esketamine exerts rapid antidepressant effects via multiple mechanisms: NMDA receptor antagonism, downstream signaling modulation, BDNF upregulation, synaptic plasticity enhancement, and neural circuit remodeling. Available studies suggest that esketamine may provide rapid antidepressant effects in oncology populations, particularly in perioperative settings. Common adverse events\u2014such as transient dissociation and elevated blood pressure\u2014are generally controllable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Esketamine, as a rapidly acting antidepressant, has a plausible mechanistic rationale and potential clinical value in the treatment of cancer-related depressive states. However, its long-term safety, optimal dosing regimens, and individualized application in different cancer patients still require further investigation. In the future, the integration of multi-omics technologies and clinical translational research should be promoted to advance the precision and standardization of its application in cancer-related depressive states treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1781915","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:21Z","timestamp":1785385341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The application of esketamine in cancer-related depressive states: attention from mechanisms to clinical translation"],"prefix":"10.3389","volume":"17","author":[{"given":"Liangju","family":"Chen","sequence":"first","affiliation":[{"name":"Central Laboratory, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]},{"name":"School of Life Science, South China Normal University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Chen","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Central Laboratory, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Feng","sequence":"additional","affiliation":[{"name":"Central Laboratory, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]},{"name":"School of Life Science, South China Normal University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Song","sequence":"additional","affiliation":[{"name":"Central Laboratory, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmei","family":"Xie","sequence":"additional","affiliation":[{"name":"Central Laboratory, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[{"name":"Central Laboratory, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"He","sequence":"additional","affiliation":[{"name":"Central Laboratory, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Affiliated Panyu Central Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3409","article-title":"Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments","volume":"23","author":"Krebber","year":"2014","journal-title":"Psycho-oncology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.12.011","article-title":"The prevalence of depression and suicidal ideation among cancer patients in mainland China and its provinces, 1994-2021: a systematic review and meta-analysis of 201 cross-sectional studies","volume":"323","author":"Ding","year":"2023","journal-title":"J Affect Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/11599770-000000000-00000","article-title":"Ketamine for treatment-resistant unipolar depression: current evidence","volume":"26","author":"Mathew","year":"2012","journal-title":"CNS Drugs"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/17448069241239231","article-title":"Esketamine inhibits the c-Jun N-terminal kinase pathway in the spinal dorsal horn to relieve bone cancer pain in rats","volume":"20","author":"Duan","year":"2024","journal-title":"Mol Pain"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313098","article-title":"Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: a review","volume":"25","author":"Pardossi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12871-024-02681-9","article-title":"Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trial","volume":"24","author":"Jiang","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030442","article-title":"Synaptic plasticity abnormalities in fetal alcohol spectrum disorders","volume":"12","author":"Basavarajappa","year":"2023","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2016.20.1.1","article-title":"Neural circuit remodeling and structural plasticity in the cortex during chronic pain","volume":"20","author":"Kim","year":"2016","journal-title":"Korean J Physiol Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-024-04719-x","article-title":"Central nervous system regulation of diffuse glioma growth and invasion: from single unit physiology to circuit remodeling","volume":"169","author":"Picart","year":"2024","journal-title":"J Neuro-Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1659153","article-title":"Role of depression-mediated alterations in pro-inflammatory cytokines in carcinogenesis","volume":"16","author":"Cao","year":"2025","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282206","article-title":"Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival","volume":"18","author":"Andersen","year":"2023","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3322\/caac.21733","article-title":"Examining the interrelationships between mindfulness-based interventions, depression, inflammation, and cancer survival","volume":"72","author":"Marinovic","year":"2022","journal-title":"CA: A Cancer J For Clin"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5937\/jomb0-56862","article-title":"Esketamine modulates postoperative biochemical markers of oxidative stress, inflammation, and immune dysregulation in laparoscopic colorectal cancer surgery","volume":"44","author":"Chen","year":"2025","journal-title":"J Med Biochem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0519-3","article-title":"Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review","volume":"32","author":"Molero","year":"2018","journal-title":"CNS Drugs"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/15360288.2025.2607541","article-title":"The emerging role of ketamine and esketamine in the concurrent management of pain and depression in cancer patients: evidence and implications for practice","volume":"40","author":"Moriarty","year":"2025","journal-title":"J Pain Palliative Care Pharmacother"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Sci (New York NY)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1124\/pr.119.018697","article-title":"Encoding, consolidation, and renormalization in depression: synaptic homeostasis, plasticity, and sleep integrate rapid antidepressant effects","volume":"72","author":"Rantam\u00e4ki","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2025.12.023","article-title":"Network pharmacology of cellular targets in major depressive disorder and differential mechanisms of fluoxetine, ketamine and esketamine","volume":"31","author":"Tapia-Gonzalez","year":"2026","journal-title":"Comput Struct Biotechnol J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"20837","DOI":"10.1038\/s41598-023-47931-x","article-title":"Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive\u2013compulsive disorder: a systematic review and meta-analysis of randomized clinical trials","volume":"13","author":"Eissazade","year":"2023","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s106752","article-title":"A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults","volume":"12","author":"Cui","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-024-00400-1","article-title":"Efficacy, safety, and tolerability of serotonin-norepinephrine reuptake inhibitors in controlling ADHD symptoms: a systematic review and meta-analysis","volume":"31","author":"Dezfouli","year":"2024","journal-title":"Middle East Curr Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2174\/157015909790031201","article-title":"Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise","volume":"7","author":"Marks","year":"2009"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241237870","article-title":"Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression","volume":"38","author":"Erritzoe","year":"2024"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127815","article-title":"Efficacy and safety of antidepressants for the treatment of irritable bowel syndrome: a meta-analysis","volume":"10","author":"Xie","year":"2015"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.53350\/pjmhs2023175455","article-title":"Amitriptyline, pregabalin, and gabapentin: efficacy and safety in neuropathic pain treatment: a single center study","volume":"17","author":"Ali","year":"2023"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac100","article-title":"Serotonin\u2013norepinephrine reuptake inhibitor antidepressant effects on regional connectivity of the thalamus in persistent depressive disorder: evidence from two randomized, double-blind, placebo-controlled clinical trials","volume":"4","author":"Yang","year":"2022"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac278","article-title":"Different depression: motivational anhedonia governs antidepressant efficacy in Huntington\u2019s disease","volume":"4","author":"McLauchlan","year":"2022"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.780921","article-title":"The mechanism, clinical efficacy, safety, and dosage regimen of atomoxetine for ADHD therapy in children: a narrative review","volume":"12","author":"Fu","year":"2022"},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.22365\/jpsych.2021.050","article-title":"Pharmacology of ketamine and esketamine as rapid-acting antidepressants","volume":"32","author":"Pavlidi","year":"2021","journal-title":"Psychiatrike = Psychiatriki"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28817","article-title":"Esketamine vs midazolam in boosting the efficacy of oral antidepressants for major depressive disorder: a pilot randomized clinical trial","volume":"6","author":"Xiao","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS Drugs"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s388764","article-title":"Efficacy and safety of esketamine combined with antidepressants for treatment-resistant depression: a meta-analysis","volume":"18","author":"Liu","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2013.804195","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"World J Biol Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.16407","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet (London England)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10181","article-title":"Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study","volume":"77","author":"Zajecka","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pharmthera.2012.08.015","article-title":"The genetics of selective serotonin reuptake inhibitors","volume":"136","author":"Kroeze","year":"2012","journal-title":"Pharmacol Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115599385","article-title":"Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale","volume":"29","author":"Montejo","year":"2015","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ph3010019","article-title":"The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments","volume":"3","author":"MaChado-Vieira","year":"2010","journal-title":"Pharm (Basel Switzerland)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"20837","DOI":"10.1038\/s41598-023-47931-x","article-title":"Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: a systematic review and meta-analysis of randomized clinical trials","volume":"13","author":"Eissazade","year":"2023","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659061","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"2014","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectrums"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124030-00003","article-title":"Antidepressant discontinuation syndromes","volume":"24","author":"Haddad","year":"2001","journal-title":"Drug Saf"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab050","article-title":"Efficacy and safety of seltorexant as adjunctive therapy in major depressive disorder: a phase 2b, randomized, placebo-controlled, adaptive dose-finding study","volume":"24","author":"Savitz","year":"2021"},{"key":"B48","first-page":"1","article-title":"Opioid guidelines in the management of chronic non-cancer pain","volume":"9","author":"Trescot","year":"2006","journal-title":"Pain Physician"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd006528.pub2","article-title":"Mirtazapine versus other antidepressive agents for depression","volume":"12","author":"Watanabe","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: Double-blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: Results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12935-025-03664-7","article-title":"Esketamine reduces postoperative depression in breast cancer through TREK-1 channel inhibition and neurotransmitter modulation","volume":"25","author":"Xu","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075767","article-title":"Influence of low-dose esketamine on postoperative depressive symptoms in patients with breast cancer (EASE): Study protocol for a randomised controlled trial","volume":"13","author":"Wei","year":"2023","journal-title":"BMJ Open"},{"key":"B55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12888-024-05753-9","article-title":"Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: A randomised, controlled, double-blind trial","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1128406","article-title":"Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: A randomized controlled trial","volume":"14","author":"Gan","year":"2023","journal-title":"Front Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2025.04.077","article-title":"Efficacy and safety of esketamine for smoking cessation among patients diagnosed with lung cancer and major depression disorder: A randomized, placebo-controlled clinical trial","volume":"383","author":"Hong","year":"2025","journal-title":"J Affect Disord"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000042284","article-title":"The effect of esketamine on postoperative anxiety and depression in patients with thyroid cancer: A randomized, double-blind, placebo-controlled, parallel-group trial","volume":"104","author":"Bi","year":"2025","journal-title":"Medicine"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.12659\/msm.922028","article-title":"Use of various doses of S-ketamine in treatment of depression and pain in cervical carcinoma patients with mild\/moderate depression after laparoscopic total hysterectomy","volume":"26","author":"Wang","year":"2020","journal-title":"Med Sci Monit"},{"key":"B60","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s13063-023-07575-8","article-title":"Effect of postoperative application of esketamine on postoperative depression and postoperative analgesia in patients undergoing pancreatoduodenectomy: A randomized controlled trial protocol","volume":"24","author":"Yu","year":"2023","journal-title":"Trials"},{"key":"B61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12871-024-02450-8","article-title":"Effectiveness of perioperative low-dose esketamine infusion for postoperative pain management in pediatric urological surgery: A prospective clinical trial","volume":"24","author":"Xie","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116559","article-title":"Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov","volume":"350","author":"Swieczkowski","year":"2025","journal-title":"Psychiatry Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240515","article-title":"Esketamine treatment for depression in adults: A PRISMA systematic review and meta-analysis","volume":"182","author":"Fountoulakis","year":"2025","journal-title":"Am J Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000039484","article-title":"A real-world pharmacovigilance study of esketamine nasal spray","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2025.05.028","article-title":"Effects of esketamine on postoperative depression in breast cancer patients: A systematic review and meta-analysis","volume":"48","author":"He","year":"2025","journal-title":"Asian J Surg"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaa120","article-title":"Implementing precision psychiatry: A systematic review of individualized prediction models for clinical practice","volume":"47","author":"Salazar De Pablo","year":"2021","journal-title":"Schizophr Bull"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00554","article-title":"Using EEG-guided basket and umbrella trials in psychiatry: A precision medicine approach for cognitive impairment in schizophrenia","volume":"9","author":"Joshi","year":"2018","journal-title":"Front Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098194","article-title":"Nanotechnology in targeted drug delivery","volume":"24","author":"Di Stefano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1417399","article-title":"Ligand-conjugated multiwalled carbon nanotubes for cancer targeted drug delivery","volume":"15","author":"Thakur","year":"2024","journal-title":"Front Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105545","article-title":"Nanotechnology-based strategy for enhancing therapeutic efficacy in pancreatic cancer: Receptor-targeted drug delivery by somatostatin analog","volume":"25","author":"Gu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401373","article-title":"An immune-enhancing injectable hydrogel loaded with esketamine and DDP promotes painless immunochemotherapy to inhibit breast cancer growth","volume":"13","author":"Yin","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/crj.70108","article-title":"The early effects of esketamine on the tumor metastatic microenvironment in postoperative lung cancer patients","volume":"19","author":"Wang","year":"2025","journal-title":"Clin Respir J"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1781915\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:22Z","timestamp":1785385342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1781915\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":72,"alternative-id":["10.3389\/fpsyt.2026.1781915"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1781915","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1781915"}}